Market Closed -
Nasdaq
04:00:00 2024-07-12 pm EDT
5-day change
1st Jan Change
22.06
USD
-0.81%
-2.86%
+11.70%
Presentation Operator MessageOperator (Operator)Greetings, and welcome to PetIQ, Inc. First Qu...
Transcript : PetIQ, Inc., Q1 2024 Earnings Call, May 08, 2024
May. 08
Earnings Flash (PETQ) PETIQ Reports Q1 Revenue $308.4M, vs. Street Est of $300.4M
May. 08
MT
Earnings Flash (PETQ) PETIQ Posts Q1 EPS $0.58
May. 08
MT
PetIQ, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Revises Earnings Guidance for the Full Year 2024
May. 08
CI
PetIQ, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 08
CI
PetIQ, Inc. Announces Expansion of Minties Dental Treats Brand with Launch of New Dental Chew for Large-Sized Dogs
Mar. 14
CI
Transcript : PetIQ, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Feb. 28
Earnings Flash (PETQ) PETIQ Reports Q4 Revenue $219.9M, vs. Street Est of $189M
Feb. 28
MT
Petiq, Inc. Provides Sales Guidance for the First Quarter and Full Year of 2024
Feb. 28
CI
PetIQ, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Feb. 28
CI
PetIQ, Inc.'s New Sentry?? Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond
Dec. 20
CI
Tranche Update on PetIQ, Inc.'s Equity Buyback Plan announced on September 6, 2022.
Nov. 07
CI
PetIQ, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 07
CI
Transcript : PetIQ, Inc., Q3 2023 Earnings Call, Nov 07, 2023
Nov. 07
Petiq, Inc. Provides Earnings Guidance for the Full Year of 2023
Nov. 07
CI
Earnings Flash (PETQ) PETIQ Reports Q3 EPS $0.42
Nov. 07
MT
Earnings Flash (PETQ) PETIQ Posts Q3 Revenue $277M, vs. Street Est of $229.1M
Nov. 07
MT
Truist Securities Raises PetIQ's Price Target to $30 From $25, Keeps Buy Rating
23-10-02
MT
PetIQ, Inc.(NasdaqGS:PETQ) added to S&P Health Care Services Select Industry Index
23-09-18
CI
Lake Street Initiates PetIQ at Buy Rating With $28 Price Target
23-09-06
MT
Tranche Update on PetIQ, Inc.'s Equity Buyback Plan announced on September 6, 2022.
23-08-09
CI
Earnings Flash (PETQ) PETIQ Reports Q2 Revenue $314.5M, vs. Street Est of $273.8M
23-08-08
MT
Earnings Flash (PETQ) PETIQ Reports Q2 EPS $0.46, vs. Street Est of $0.26
23-08-08
MT
Transcript : PetIQ, Inc., Q2 2023 Earnings Call, Aug 08, 2023
23-08-08
PetIQ, Inc. Provides Earnings Guidance for the Third Quarter of 2023
23-08-08
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segmentâs services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
More about the company
Last Close Price
22.06
USD
Average target price
29.33
USD
Spread / Average Target
+32.97%
Consensus
1st Jan change
Capi.
+11.70% 647M -9.29% 81.7B -7.35% 6.82B +33.75% 3.96B +19.93% 1.76B -4.00% 1.27B -37.88% 1.03B -42.33% 963M -19.10% 846M -35.67% 840M
Veterinary Drugs
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1